VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth -5.3% ·
share flow +5.0% ·
net new positions -5.6%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 148 | -1 | 754.00M | $11.97B | +6 | −8 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | — | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | — |
| Q2 2024 | 18 | — | 121.66M | $1.29B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 74.46M | +26.9% | $648.56M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (passive) | 61.46M | -3.6% | $535.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 31.17M | +3.7% | $270.70M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 12.48M | +9.0% | $108.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Glenview Capital ✦ | 8.49M | -8.9% | $73.97M | 1.8% | ▼ Trim | 4 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 6.15M | -38.2% | $53.58M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 7 | Greenlight Capital (DME Capital) ✦ | 6.00M | +3.7% | $52.27M | 2.6% | ▲ Add | 4 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 3.30M | -12.5% | $28.70M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 2.18M | +15.8% | $18.82M | 0.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 10 | Two Sigma Investments ✦ | 1.55M | +856.0% | $13.54M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 895.14K | +73.3% | $7.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 814.51K | -46.4% | $7.09M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 663.41K | New | $5.78M | 0.0% | New | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 610.87K | -73.4% | $5.32M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | GAMCO Investors ✦ | 314.19K | +3.6% | $2.74M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Marshall Wace ✦ | 259.45K | -77.9% | $2.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Capital World Investors ✦ | 110.68K | 0.0% | $964,005 | 0.0% | Held | 4 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 13.83K | -17.3% | $120,423 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $5.78M | 0.0% |
Exited
| D. E. Shaw & Co. | $1.66M | was 0.0% |
| Wellington Management | $848,442 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,011 holders, 984.50M shares, $12.02B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.